Sunday, June 20, 2021
News

New vaccine blocks Covid-19, variants, other Coronaviruses

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New York | Tuesday, 2021 5:15:06 PM IST
US researchers have developed a potential new vaccine, which has proven effective against the original SARS-CoV-1, SARS-CoV-2 as well as its UK, South Africa and Brazil variants and related bat Coronaviruses that could potentially cause the next pandemic.

The new vaccine, called pan-coronavirus vaccine, was found effective in protecting monkeys and mice.

Pan-coronavirus vaccine triggers neutralising antibodies via a nanoparticle. The nanoparticle is composed of the Coronavirus part that allows it to bind to the body's cell receptors and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans, said researchers from the Duke University in North Carolina, US.

The findings, published in the journal Nature, showed that the nanoparticle vaccine, in monkeys, blocked Covid-19 infection by 100 per cent. The new vaccine also elicited significantly higher neutralising levels in the animals than current vaccine platforms or natural infection in humans.

"We began this work last spring with the understanding that, like all viruses, mutations would occur in the SARS-CoV-2 virus, which causes Covid-19," said senior author Barton F Haynes, director of the Duke Human Vaccine Institute (DHVI).

"The mRNA vaccines were already under development, so we were looking for ways to sustain their efficacy once those variants appeared.

"This approach not only provided protection against SARS-CoV-2, but the antibodies induced by the vaccine also neutralised variants of concern that originated in the UK, South Africa and Brazil. And the induced antibodies reacted with quite a large panel of coronaviruses," Haynes said.

The team built on earlier studies involving SARS, the respiratory illness caused by a coronavirus called SARS-CoV-1. They found a person who had been infected with SARS developed antibodies capable of neutralising multiple coronaviruses, suggesting that a pan-coronavirus might be possible.

They identified one particular receptor-binding domain site that is present on SARS-CoV-2, its circulating variants and SARS-related bat viruses that makes them highly vulnerable to cross-neutralising antibodies.

The team then designed a nanoparticle displaying this vulnerable spot. The nanoparticle is combined with a small molecule adjuvant, which boosts the body's immune response to fight the disease.

--IANS rvt/in

( 360 Words)

2021-05-11-11:02:02 (IANS)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Study finds common antibiotic useful in ...
Stem cell researchers find key building ...
Russia adds 17,906 Covid cases...
Third wave of Covid 'definitely under wa...
US administers 300 mn Covid-19 shots in ...
S.African military personnel to help hos...
More...
 
INDIA WORLD ASIA
193 fresh COVID-19 infections in Mizoram...
'PhD in tax recovery': Rahul Gandhi's ji...
Youth opens fire at lover before shootin...
India records 58,419 new COVID-19 cases,...
Maharashtra reports 8,912 new COVID-19 c...
Gujarat's Dahod becomes role model in pr...
More...    
 
 Top Stories
Newly constructed section of road o... 
Odisha CM condoles demise of Odia p... 
Bollywood celebrities extend Father... 
'It's cloudy but no rain': Dinesh K... 
Pakistan's Punjab witnessing shorta... 
NGT suggests Haryana govt to ensure... 
Father's Day: Tendulkar takes trip ... 
COVID 19: Over 29.10 crore vaccine ...